Bladder Cancer, An Issue of Hematology/Oncology Clinics of North America
- 1 Edición, Volumen 29-2 - 14 de abril de 2015
- Última edición
- Autor: Joaquim Bellmunt
- Idioma: Inglés
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and… Leer más
Descripción
Descripción
This issue of Hematology/Oncology Clinics of North America, guest edited by Dr. Joaquin Bellmunt, is devoted to Bladder Cancer. Articles in this issue include: Diagnosis and Staging of Bladder Cancer; Epidemiology of Bladder Cancer; Molecular Biology of Bladder Cancer; Pharmacogenomics in Bladder Cancer; Management of Non-muscle Invasive Bladder Cancer; Non-urothelial Bladder Cancer and Rare Variant Histologies; Management of UUT; New Trends in Surgical Management of Bladder Cancer; Bladder Preservation Strategies; Perioperative Therapy of Bladder Cancer (Neoadjuvant and Adjuvant); First Line Treatment and Prognostic Factors of Metastatic Disease: Platinum Eligible Patients; First Line Treatment of Metastatic Disease: Platinum Ineligible Patients; Salvage Therapy in Metastatic Disease; and Future Directions and Targeted Therapies in Bladder Cancer.
Detalles del producto
Detalles del producto
- Edición: 1
- Última edición
- Volumen: 29-2
- Publicado: 3 de junio de 2015
- Idioma: Inglés
Sobre el autor
Sobre el autor
JB
Joaquim Bellmunt
Afiliaciones y experiencia
Director, Bladder Cancer Center
Dana-Farber Cancer Institute
Dana-Farber/Brigham and Women's Cancer Center
Associate Professor, Harvard Medical School